X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (73) 73
humans (70) 70
male (47) 47
female (40) 40
hematology (37) 37
middle aged (36) 36
oncology (35) 35
animals (25) 25
adult (24) 24
aged (18) 18
expression (18) 18
lymphomas (18) 18
mice (18) 18
analysis (17) 17
mutation (17) 17
medicine & public health (16) 16
cancer (14) 14
leukemia (14) 14
cells (13) 13
chemotherapy (13) 13
transplantation (13) 13
genetic aspects (12) 12
human necessities (12) 12
original (12) 12
stem cells (12) 12
treatment outcome (12) 12
chemistry (11) 11
metallurgy (11) 11
anemia (10) 10
compositions based thereon (10) 10
differentiation (10) 10
genes (10) 10
hygiene (10) 10
identification (10) 10
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (10) 10
medical or veterinary science (10) 10
medicine, general & internal (10) 10
organic macromolecular compounds (10) 10
patients (10) 10
preparations for medical, dental, or toilet purposes (10) 10
proteins (10) 10
remission induction (10) 10
rituximab (10) 10
specific use of cosmetics or similar toiletpreparations (10) 10
their preparation or chemical working-up (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
care and treatment (9) 9
lymphoma (9) 9
medicine, research & experimental (9) 9
survival (9) 9
young adult (9) 9
biochemistry & molecular biology (8) 8
hemoglobin (8) 8
molecular sequence data (8) 8
original article (8) 8
original articles (8) 8
prognosis (8) 8
therapy (8) 8
b-cell lymphoma (7) 7
bone marrow (7) 7
cell biology (7) 7
erythropoiesis (7) 7
gene (7) 7
gene expression (7) 7
genetic research (7) 7
hemic and lymphatic diseases (7) 7
japan (7) 7
k562 cells (7) 7
medical colleges (7) 7
relapse (7) 7
research article (7) 7
virology (7) 7
adolescent (6) 6
binding (6) 6
cell line (6) 6
cells, cultured (6) 6
combined modality therapy (6) 6
cord blood transplantation (6) 6
diagnosis (6) 6
diseases (6) 6
erythroblasts - metabolism (6) 6
gene-expression (6) 6
hematopoietic stem cells (6) 6
medical research (6) 6
medicine, experimental (6) 6
mice, inbred icr (6) 6
mice, knockout (6) 6
non-hodgkins-lymphoma (6) 6
polymerase chain reaction (6) 6
risk factors (6) 6
rna (6) 6
activation (5) 5
aged, 80 and over (5) 5
amino acid sequence (5) 5
biology (5) 5
biophysics (5) 5
cell differentiation - genetics (5) 5
cell line, tumor (5) 5
clinical research (5) 5
clinical trials (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2017, Volume 58, Issue 10, p. 2020
Follicular lymphoma (FL) is incurable with the current standard therapeutic strategy, although the natural history of FL has improved in the last few decades.... 
Recurrence | Lymphoma, Follicular - therapy | Early Medical Intervention | Humans | Lymphoma, Follicular - diagnosis | Antineoplastic Agents | Tumor Burden | Disease Progression
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 02/2015, Volume 73, pp. 195 - 197
Journal Article
Cancer Science, ISSN 1347-9032, 05/2017, Volume 108, Issue 5, pp. 1007 - 1012
Journal Article
International Journal of Hematology, ISSN 0925-5710, 3/2019, Volume 109, Issue 3, pp. 366 - 368
Byline: Kensei Tobinai (1), Toshiki Uchida (2), Noriko Fukuhara (3), Tomoaki Nishikawa (4) Author Affiliation: (1) 0000 0001 2168 5385, grid.272242.3,... 
Medicine & Public Health | Hematology | Oncology | HEMATOLOGY | Analysis | Cancer | Lymphocytes B | Refractory materials
Journal Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, ISSN 0368-2811, 04/2019, Volume 49, Issue 4, pp. 306 - 310
The introduction of a chimeric anti-CD20 monoclonal antibody, rituximab, for the treatment of follicular lymphoma (FL) has dramatically improved the prognosis... 
SURVIVAL | low tumor burden | IMMUNOCHEMOTHERAPY | follicular lymphoma | WATCH | INDOLENT | CLINICAL-PRACTICE GUIDELINES | TRIAL | ANTI-CD20 MONOCLONAL-ANTIBODY | THERAPY | ONCOLOGY | RITUXIMAB | OUTCOMES | rituximab monotherapy | watchful waiting
Journal Article
Cancer Science, ISSN 1347-9032, 06/2018, Volume 109, Issue 6, pp. 2056 - 2062
Journal Article
Cancer Science, ISSN 1347-9032, 12/2016, Volume 107, Issue 12, pp. 1785 - 1790
Journal Article
STEM CELLS, ISSN 1066-5099, 03/2017, Volume 35, Issue 3, pp. 739 - 753
Mesenchymal stromal cells (MSCs) are multipotent progenitor cells and there is much interest in how MSCs contribute to the regulation of the tumor... 
Hematologic malignancies | Adult stem cells | Marrow stromal stem cells | Tissue‐specific stem cells | Bone marrow stromal cells | Marrow stromal cells | Mesenchymal stem cells | Tissue-specific stem cells | STEM-CELLS | SENSITIVITY | SUPPRESSION | CHEMOTHERAPY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | BREAST-CANCER | MICROENVIRONMENT | ONCOLOGY | LYSOPHOSPHOLIPIDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DISEASE | MALIGNANCIES | INHIBITOR | HEMATOLOGY | Receptors, Lysophosphatidic Acid - metabolism | Up-Regulation | Cell Proliferation | Cancer-Associated Fibroblasts - metabolism | Humans | Cellular Senescence | Cell Transdifferentiation | Female | Receptors, Lysophosphatidic Acid - antagonists & inhibitors | Phosphoric Diester Hydrolases - metabolism | Signal Transduction | Mesenchymal Stromal Cells - metabolism | Multiple Myeloma - blood supply | Disease Progression | Carcinogenesis - pathology | Xenograft Model Antitumor Assays | Cancer-Associated Fibroblasts - pathology | Multiple Myeloma - pathology | Animals | Mice, Nude | Cell Line, Tumor | Mice, Inbred BALB C | Neovascularization, Pathologic - metabolism | Mesenchymal Stromal Cells - pathology | RNA, Small Interfering - metabolism | Physiological aspects | Development and progression | Growth | Multiple myeloma | Stem cells | Plasma | Senescence | Mesenchyme | Biosynthesis | Vascularization | Lysophosphatidic acid receptors | Angiogenesis | Receptors | Reproduction | Control | Lysophosphatidic acid | Stromal cells | Cells (biology) | Bone marrow | Plasma cells | In vitro methods and tests
Journal Article
Cancer Science, ISSN 1347-9032, 08/2017, Volume 108, Issue 8, pp. 1634 - 1639
The outcomes of cord blood transplantation with non‐irradiated reduced‐intensity conditioning for hematological malignancies need to be improved because of... 
engraftment | intrabone | non‐myeloablative conditioning | hematological malignancy | Cord blood transplantation | non-myeloablative conditioning | SUCCESSFUL ENGRAFTMENT | CELL TRANSPLANTATION | GRAFT | VERSUS-HOST-DISEASE | FLUDARABINE | INTENSITY PREPARATIVE REGIMEN | ACUTE-LEUKEMIA | ADULT RECIPIENTS | ONCOLOGY | INJECTION | UNRELATED BONE-MARROW | Hematologic Neoplasms - therapy | Neutrophils - cytology | Graft vs Host Disease - epidemiology | Humans | Middle Aged | Reticulocyte Count | Male | Treatment Outcome | Vidarabine - analogs & derivatives | Young Adult | Cord Blood Stem Cell Transplantation - methods | Cord Blood Stem Cell Transplantation - adverse effects | Injections | Platelet Count | Hematologic Neoplasms - blood | Cryopreservation | Adolescent | Survival Analysis | Adult | Female | Vidarabine - administration & dosage | Transplantation Conditioning | Medicine, Experimental | Medical research | Histocompatibility antigens | Analysis | HLA histocompatibility antigens | Cancer | Transplants & implants | Leukemia | Prophylaxis | Irradiated | Transplantation | Malignancy | Blood platelets | Cord blood | Bone marrow | Methotrexate | Drug dosages | Cell survival | Hematology | Research & development--R&D | Blood cells | Neutrophils | Leukocytes (neutrophilic) | Reticulocytes | Blood banks | Patients | Rejection | Grafts | Fludarabine | Tacrolimus | Histocompatibility antigen HLA | Leukocytes (granulocytic) | Original
Journal Article
by Kim, Ellen J and Kim, Youn H and Bagot, Martine and Pinter-Brown, Lauren and Rook, Alain H and Porcu, Pierluigi and Horwitz, Steven M and Whittaker, Sean and Tokura, Yoshiki and Vermeer, Maarten and Zinzani, Pier Luigi and Sokol, Lubomir and Morris, Stephen and Ortiz-Romero, Pablo L and Eradat, Herbert and Scarisbrick, Julia and Tsianakas, Athanasios and Elmets, Craig and Dalle, Stephane and Fisher, David C and Halwani, Ahmad and Poligone, Brian and Greer, John and Fierro, Maria Teresa and Khot, Amit and Moskowitz, Alison J and Musiek, Amy and Shustov, Andrei and Pro, Barbara and Geskin, Larisa J and Dwyer, Karen and Moriya, Junji and Leoni, Mollie and Humphrey, Jeffrey S and Hudgens, Stacie and Grebennik, Dmitri O and Tobinai, Kensei and Duvic, Madeleine and Abhyankar, Sunil and Akilov, Oleg and Alpdogan, Onder and Beylot-Barry, Marie and Boh, Erin and Caballero, Dolores and Cowan, Richard and Dreno, Brigitte and Dummer, Reinhard and Fenske, Timothy and Foss, Francine and Fukuhara, Noriko and Giri, Pratyush and Habe, Koji and Hamada, Toshihisa and Hatake, Kiyohiko and Iida, Shinsuke and Ishikawa, Osamu and Iversen, Lars and Kiyohara, Eiji and Koga, Hiroshi and Korman, Neil and Kuss, Bryone Jean and Lamar, Zanetta and Lansigan, Frederick and Lechowicz, Mary Jo and Lerner, Adam and Magnolo, Nina and Mark, Lawrence and Miyagaki, Tomomitsu and Munoz, Javier and Nicolay, Jan Peter and Nishiwaki, Kaoru and Okamoto, Hiroyuki and Ohtsuka, Mikio and Pacheco, Theresa and Querfeld, Christiane and Rapini, Ronald Peter and Sano, Shigetoshi and Tanaka, Maiko and Tharp, Michael D and Uehara, Jiro and Wada, Hidefumi and Wells, Jillian and Wilcox, Ryan A and William, Basem and Yonekura, Kentaro and MAVORIC Investigators
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1192 - 1204
Journal Article